Adhesion molecules in lymphocyte trafficking and colitis

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 1008-1010

  Ley, Klaus ^a   Burns, Cartland ^b  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CELL ADHESION MOLECULE; INTEGRIN; L SELECTIN;

COLITIS; CROHN DISEASE; EDITORIAL; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE ADHESION DEFICIENCY; LYMPHOCYTE TRANSFER; MUCOSAL IMMUNITY; PRIORITY JOURNAL;

EID: 0034798496     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.28635     Document Type: Article

References (25)

1. Immune cell trafficking in utero and during early life is dominated by the mucosal addressin MAdCAM-1 in man
2. Dysfunctional LAD-1 neutrophils and colitis
3. Physiological and molecular mechanisms of lymphocyte homing
4. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue
5. Leucocyte adhesion deficiency presenting as a chronic ileocolitis
6. Leukocyte adhesion deficiency syndrome: Insights into the molecular basis of leukocyte emigration
7. Spontaneous skin ulceration and defective T cell function in CD18 null mice
8. Recurrent septicaemia in a neutropenic patient with typhlitis
9. Typhlitis complicating autologous blood stem cell transplantation for breast cancer
10. Leukocyte adhesion deficiency type II
11. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice
12. Severe inflammatory defect and reduced viability in CD18 and E-selectin double mutant mice
13. Is Crohn's disease an immunodeficiency? A hypothesis suggesting early events in the pathogenesis of Crohn's disease
14. Immunostimulation in Crohn's disease: Results of a pilot study of G-CSF in mucosal and fistulizing Crohn's disease
15. Mechanisms of granulocytosis in the absence of CD18
16. Increased granulopoiesis through IL-17 and G-CSF in adhesion molecule-deficient mice
17. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease
18. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression
19. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells
20. Selective antibody blockade of lymphocyte migration to mucosal sites and mast cell adhesion
21. Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist
22. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
23. Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation
24. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents
25. Integrin antagonists